(Q42245717)

English

Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan

scientific article published on 3 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Bushra Moiz

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Tariq Moatter

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Usman Shaikh

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Salman Adil

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Natasha Ali

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Farheen Mahar

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Naseem Shamsuddin

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Mohammad Khurshid

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

3 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1652-1659

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? A prospective study, the results of 18,200 blood donors from the Turkish Red Crescent.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Hepatitis B virus blood screening: unfinished agendas

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Kinetics of acute hepatitis B virus infection in humans.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Trend of transfusion transmitted infections frequency in blood donors: provide a road map for its prevention and control

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Hepatitis C virus infection in the general population: a community-based study in West Bengal, India

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Hepatitis C virus in healthy blood donors in Sri Lanka

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Need for nucleic Acid testing in countries with high prevalence of transfusion-transmitted infections.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Nucleic acid testing (NAT) in high prevalence-low resource settings

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12521

21 January 2018

Identifiers

10.1111/TRF.12521

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42245717&oldid=1939797274"